US FDA Finalizes Nonclinical Test Guidance Intended To Spur NDAs For Novel NRTs

Final guidance tracks nearly word-for-word with draft document detailing the agency’s thinking on animal studies for novel NRTs the Center for Drug Evaluation and Research published in August 2018.